• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部进展期直肠癌根治性治疗后癌胚抗原升高原因不明的分析。

Analysis of unexplained carcinoembryonic antigen elevation after curative treatment of locally advanced rectal cancer.

机构信息

Center for Colorectal Cancer, National Cancer Center, Goyang, Republic of Korea.

出版信息

Int J Clin Oncol. 2018 Oct;23(5):924-929. doi: 10.1007/s10147-018-1293-4. Epub 2018 May 17.

DOI:10.1007/s10147-018-1293-4
PMID:29774483
Abstract

BACKGROUND

To analyze the causes and patterns of unexplained carcinoembryonic antigen (CEA) elevation after curative treatment in locally advanced rectal cancer patients.

METHODS

Among the 1309 locally advanced rectal cancer patients treated with curative resection and radiotherapy between January 2001 and June 2011, 325 patients who postoperatively developed abnormal CEA elevation were reviewed. The unexplained CEA elevation was defined as a CEA level higher than 5 ng/mL with no evidence of cancer recurrence at the time of elevation.

RESULTS

Of the 325 patients, 143 (44%) had unexplained CEA elevations. The causes were categorized as delayed recurrence (n = 29, 20%), non-colorectal malignancy (n = 10, 7%), and non-malignancy-related conditions (n = 104, 73%). Shorter intervals between treatment and the first CEA elevation, and a higher peak CEA level, were observed in the delayed recurrence group compared with the non-colorectal malignancy or non-malignancy-related group (intervals of 6.8 vs. 44.9 vs. 23.2 months, respectively, p = 0.002; and peak CEA levels of 9.9 vs. 7.1 vs. 6.2 ng/mL, respectively, p = 0.034). In patients who showed delayed recurrence, the interval between the first CEA elevation and diagnosis of recurrence was a median of 13.0 months (range 3.8-60.6 months). Smoking was the most common cause for non-malignancy-related conditions. The patterns of unexplained CEA elevations were defined as sporadic (n = 78, 55%), stationary (n = 37, 26%), and increasing (n = 28, 20%). The patterns were significantly different depending on the cause (p < 0.001).

CONCLUSIONS

Analysis of the patterns of unexplained CEA elevations is a reasonable approach to predict the cause of the cancer.

摘要

背景

分析根治性治疗后局部晚期直肠癌患者癌胚抗原(CEA)升高的原因和模式。

方法

在 2001 年 1 月至 2011 年 6 月期间接受根治性切除术和放疗的 1309 例局部晚期直肠癌患者中,回顾分析了术后出现 CEA 异常升高的 325 例患者。将无法解释的 CEA 升高定义为升高时 CEA 水平高于 5ng/mL 且无癌症复发证据。

结果

325 例患者中,143 例(44%)出现无法解释的 CEA 升高。其原因分为延迟复发(29 例,20%)、非结直肠癌恶性肿瘤(10 例,7%)和非恶性相关疾病(104 例,73%)。与非结直肠癌恶性肿瘤或非恶性相关疾病组相比,延迟复发组治疗后首次 CEA 升高的间隔时间更短,峰值 CEA 水平更高(间隔分别为 6.8、44.9 和 23.2 个月,p=0.002;峰值 CEA 水平分别为 9.9、7.1 和 6.2ng/mL,p=0.034)。在出现延迟复发的患者中,首次 CEA 升高和复发诊断之间的间隔中位数为 13.0 个月(范围 3.8-60.6 个月)。吸烟是非恶性相关疾病最常见的原因。无法解释的 CEA 升高的模式定义为散发性(78 例,55%)、静止性(37 例,26%)和递增性(28 例,20%)。这些模式与病因明显不同(p<0.001)。

结论

分析无法解释的 CEA 升高的模式是预测癌症病因的合理方法。

相似文献

1
Analysis of unexplained carcinoembryonic antigen elevation after curative treatment of locally advanced rectal cancer.局部进展期直肠癌根治性治疗后癌胚抗原升高原因不明的分析。
Int J Clin Oncol. 2018 Oct;23(5):924-929. doi: 10.1007/s10147-018-1293-4. Epub 2018 May 17.
2
Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer.根治性切除 I-III 期直肠癌术后癌胚抗原水平升高和正常化对预后的影响。
Cancer Med. 2020 Jan;9(2):653-662. doi: 10.1002/cam4.2758. Epub 2019 Dec 4.
3
Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence.直肠癌的联合治疗模式:治疗后与治疗前 CEA 作为疾病复发的预后标志物的相对价值。
Ann Surg Oncol. 2012 Aug;19(8):2471-6. doi: 10.1245/s10434-012-2266-x. Epub 2012 Feb 11.
4
Can normalized carcinoembryonic antigen following neoadjuvant chemoradiation predict tumour recurrence after curative resection for locally advanced rectal cancer?新辅助放化疗后癌胚抗原正常化能否预测局部进展期直肠癌根治性切除术后肿瘤复发?
Colorectal Dis. 2021 Jun;23(6):1346-1356. doi: 10.1111/codi.15583. Epub 2021 Feb 25.
5
Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.术前放化疗和根治性切除治疗直肠癌患者的化疗前后 s-CEA 降低率的临床意义。
Ann Surg Oncol. 2011 Nov;18(12):3271-7. doi: 10.1245/s10434-011-1740-1. Epub 2011 May 3.
6
Can serum dynamics of carcinoembryonic antigen level during neoadjuvant chemoradiotherapy in rectal cancer predict tumor response and recurrence? A multi-institutional retrospective study.直肠癌新辅助放化疗期间癌胚抗原水平的血清动力学能否预测肿瘤反应和复发?一项多机构回顾性研究。
Int J Colorectal Dis. 2016 Sep;31(9):1595-601. doi: 10.1007/s00384-016-2629-z. Epub 2016 Jul 28.
7
Prognostic Effect of Pretreatment Serum Carcinoembryonic Antigen Level: A Useful Tool for Prediction of Distant Metastasis in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.治疗前血清癌胚抗原水平的预后作用:预测新辅助放化疗及全直肠系膜切除术后局部晚期直肠癌远处转移的有用工具。
Medicine (Baltimore). 2015 Aug;94(31):e1291. doi: 10.1097/MD.0000000000001291.
8
Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.血清癌胚抗原水平围手术期变化的预后效应:检测直肠癌全身复发的有用工具。
Ann Surg Oncol. 2006 May;13(5):645-50. doi: 10.1245/ASO.2006.03.090. Epub 2006 Mar 13.
9
False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer.有结直肠癌切除史患者癌胚抗原的假阳性升高
J Natl Compr Canc Netw. 2014 Jun;12(6):907-13. doi: 10.6004/jnccn.2014.0085.
10
Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.癌胚抗原作为接受术前放化疗及手术治疗的局部晚期直肠癌患者病理反应的预测指标及预后因素。
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):810-7. doi: 10.1016/j.ijrobp.2008.08.057. Epub 2008 Dec 26.

引用本文的文献

1
Prognostic Potential of the Preoperative Controlling Nutritional Status (CONUT) Score in Predicting Survival of Patients with Cancer: A Systematic Review.术前控制营养状况(CONUT)评分对预测癌症患者生存预后的价值:一项系统评价。
Adv Nutr. 2021 Feb 1;12(1):234-250. doi: 10.1093/advances/nmaa102.

本文引用的文献

1
Serum carcinoembryonic antigen is positively associated with leukocyte count in Korean adults.在韩国成年人中,血清癌胚抗原与白细胞计数呈正相关。
J Clin Lab Anal. 2018 Mar;32(3). doi: 10.1002/jcla.22291. Epub 2017 Jun 27.
2
Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules.局部晚期直肠癌的术前放化疗:三种放疗剂量和分割方案的比较
Radiat Oncol J. 2016 Jun;34(2):96-105. doi: 10.3857/roj.2016.01704. Epub 2016 Jun 17.
3
False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer.
有结直肠癌切除史患者癌胚抗原的假阳性升高
J Natl Compr Canc Netw. 2014 Jun;12(6):907-13. doi: 10.6004/jnccn.2014.0085.
4
Factors Associated with Serum Levels of Carcinoembryonic Antigen in Healthy Non-smokers.健康非吸烟者血清癌胚抗原水平的相关因素
Korean J Fam Med. 2013 Nov;34(6):413-9. doi: 10.4082/kjfm.2013.34.6.413. Epub 2013 Nov 25.
5
No correlation between pretreatment serum CEA levels and tumor volume in locally advanced rectal cancer patients.局部进展期直肠癌患者治疗前血清 CEA 水平与肿瘤体积无相关性。
Clin Chim Acta. 2012 Feb 18;413(3-4):511-5. doi: 10.1016/j.cca.2011.11.019. Epub 2011 Nov 25.
6
Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer.预测直肠癌术前放化疗后病理肿瘤反应的临床参数。
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1167-72. doi: 10.1016/j.ijrobp.2007.04.047.
7
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.结直肠癌中的肿瘤标志物:欧洲肿瘤标志物小组(EGTM)临床应用指南
Eur J Cancer. 2007 Jun;43(9):1348-60. doi: 10.1016/j.ejca.2007.03.021. Epub 2007 May 18.
8
DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.通过免疫耐受和吸收技术证明人类结肠癌中的肿瘤特异性抗原
J Exp Med. 1965 Mar 1;121(3):439-62. doi: 10.1084/jem.121.3.439.
9
Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.结直肠癌的预后因素。美国病理学家学会1999年共识声明
Arch Pathol Lab Med. 2000 Jul;124(7):979-94. doi: 10.5858/2000-124-0979-PFICC.
10
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer.一项关于癌胚抗原(CEA)检测用于监测结肠癌切除患者的评估。
JAMA. 1993 Aug 25;270(8):943-7.